| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080456A1 Pharmaceutical composition for intracellular acidification with cis-urocanic |
| 09/23/2004 | WO2004080441A1 Patch material for ionic medicine administration |
| 09/23/2004 | WO2004080437A1 Method of delivering substance by transdermal absorption, peeling agent to be used in delivery of substance by transdermal absorption, peeling apparatus and disposable pad for peeling apparatus |
| 09/23/2004 | WO2004080415A2 Gel composition and method for treatment of vaginal infections |
| 09/23/2004 | WO2004080413A2 Uses and formulations for transdermal or transmucosal application of active agents |
| 09/23/2004 | WO2004080401A2 Oral insulin therapies and protocol |
| 09/23/2004 | WO2004080383A2 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 09/23/2004 | WO2004080382A2 Novel compositions containing fentanyl |
| 09/23/2004 | WO2004080371A2 Injectable isotonic solution of gatifloxacin pre-diluted in glucose. |
| 09/23/2004 | WO2004080284A2 Antibody-targeted photodynamic therapy |
| 09/23/2004 | WO2004069134A3 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 09/23/2004 | WO2004060348A3 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 09/23/2004 | WO2004050707A3 Tumor-specific recognition molecules |
| 09/23/2004 | WO2004049964A3 Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue |
| 09/23/2004 | WO2004047735A3 Broad spectrum anti-viral therapeutics and prophylaxis |
| 09/23/2004 | WO2004032858A3 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 09/23/2004 | WO2004014973A3 Biodegradable polymer |
| 09/23/2004 | WO2003079403A3 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
| 09/23/2004 | WO2003072017A3 Macromolecular conjugates and processes for preparing same |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003059436A3 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 09/23/2004 | WO2003046204A3 Humanized collagen antibodies and related methods |
| 09/23/2004 | WO2003046034A3 Improved synthesis of polyanhyrides |
| 09/23/2004 | WO2003037312A3 Ribavirin syrup formulations |
| 09/23/2004 | US20040186277 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186231 Dehydrated, shaped matrix and use thereof in the treatment of vascular malformation |
| 09/23/2004 | US20040186230 Composition for administration of a biologically active compound |
| 09/23/2004 | US20040186183 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 09/23/2004 | US20040186179 Pharmaceutical composition |
| 09/23/2004 | US20040186175 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040186084 Sterile aqueous composition comprising triamcinolone acetonide, and tonicity-adjusting agents, pH-adjusting agents to provide a pH of between about 5 and 7.5; treating diabetic macular edema and related illness; intravitreal injection |
| 09/23/2004 | US20040186076 Pharmaceutical complex |
| 09/23/2004 | US20040186075 Providing bioavailability by complexing a benzodiazepine drug with a cyclodextrin; chemical reversible ring-opening of small portion (at least 0.1% by weight) of drug for enhancing the complexation efficiency |
| 09/23/2004 | US20040186074 including 2-hydroxylpropyl- beta -cyclodextrin for reducing toxicity; a stable, concentrated solution has ifosfamide concentrations as high has 1,1000 mg/ml; antitumor agents |
| 09/23/2004 | US20040186064 additive-free, isotonic inhalant of pH 4.0 to 5.5; improved shelf-life at room temperature; acute and chronic endobronchial infections; cystic fibrosis |
| 09/23/2004 | US20040186063 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 09/23/2004 | US20040186056 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 09/23/2004 | US20040186050 Method for orally administering parathyroid hormone (pth) |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185524 comprises a solute and dimethylsulfoxide (DMSO) by fluid phase endocytosis to produce an internally loaded biological sample; includes freeze/vaccum drying |
| 09/23/2004 | US20040185511 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 09/23/2004 | US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate |
| 09/23/2004 | US20040185112 incorporation of a pressure nozzle and a diffuser plate to improve the flow of drying gas and a drying chamber extension to increase drying time, such improvements leading to the formation of homogeneous solid dispersions of drugs in concentration-enhancing polymers |
| 09/23/2004 | US20040185109 through the ion exchange of the cationic molecule onto the surface of a substrate having a high surface area; such as a cation/organoclay |
| 09/23/2004 | US20040185108 emulsifying in aqueous solution a solution of a polymer and a drug in a water immiscible solvent to form an oil in water emulsion, freezing and removing aqueous phase by sublimation to form porous polymer drug microparticles, introducing gas; tissue targeted therapy using ultrasound to rupture particles |
| 09/23/2004 | US20040185105 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 09/23/2004 | US20040185104 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents |
| 09/23/2004 | US20040185103 Methods and compositions for enhanced delivery of bioactive molecules |
| 09/23/2004 | US20040185101 Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
| 09/23/2004 | US20040185098 Making oral dosage form by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules |
| 09/23/2004 | US20040185096 Melt-extrusion multiparticulates |
| 09/23/2004 | US20040185095 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 09/23/2004 | US20040185093 Hydroxypropylmethylcellulose coating agent;sucralose heat-stable, high-intensity sweetener; and menthyl ester non-volatile coolant; taste masking, odorless; drug coatings |
| 09/23/2004 | US20040185084 Synthetic implant with nonimmunogenicity coating |
| 09/23/2004 | US20040185083 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 09/23/2004 | US20040185068 Self-emulsifying compositions, methods of use and preparation |
| 09/23/2004 | US20040185067 Material delivery method by skin absorption, peeling agent used for material delivery by skin absorption, peeling device, and disposable pad for peeling device |
| 09/23/2004 | US20040185065 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/23/2004 | US20040185058 Immunogenic polypeptides physically linked; anticarcinogenic, antitumor, antiallergen, and viricidal agents; autoimmune diseases; systemic or mucosal vaccines; genetic engineering |
| 09/23/2004 | US20040185053 Comprising targeting and chemotherapeutic moieties linked via thiol group; anticarcinogenic and antitumor agents; autoimmune disease and infection treatment |
| 09/23/2004 | US20040185039 Autophilically-modified antibodies bind to their respective tumor target cells with increased efficiency |
| 09/23/2004 | US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 09/23/2004 | US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices |
| 09/23/2004 | US20040185006 Delivery of stimulants through an inhalation route |
| 09/23/2004 | US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 09/23/2004 | US20040185004 Delivery of erectile dysfunction drugs through an inhalation route |
| 09/23/2004 | US20040185003 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 09/23/2004 | US20040185002 condensation aerosol for delivery of a drug selected from chlordiazepoxide, betahistine, clonidine, testosterone, a conjugated estrogen, an estrogen ester, estradiol, an estradiol ester, ethinyl estradiol, an ethinyl estradiol ester and hyoscyamine |
| 09/23/2004 | US20040185001 Delivery of physiologically active compounds through an inhalation route |
| 09/23/2004 | US20040185000 Delivery of antihistamines through an inhalation route |
| 09/23/2004 | US20040184999 Delivery of anti-migraine compounds through an inhalation route |
| 09/23/2004 | US20040184998 Delivery of drug esters through an inhalation route |
| 09/23/2004 | US20040184997 volatilizing a coating of drug on a solid support, having the surface texture of a metal foil, to a temperature sufficient to produce a heated vapor of drug and condensing the heated vapor to form condensation aerosol particles |
| 09/23/2004 | US20040184996 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 09/23/2004 | US20040184993 allows the modulation of the mass median aerodynamic diameter of the aerosol particles on actuation of the inhaler to a value which is suited for the pulmonary administration |
| 09/23/2004 | US20040184992 Mousse composition |
| 09/23/2004 | DE10310196A1 Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose Use of a tricyclic antidepressant to promote endocytosis |
| 09/23/2004 | CA2530166A1 Antibody-targeted photodynamic therapy |
| 09/23/2004 | CA2529819A1 Pegylated single domain antibodies |
| 09/23/2004 | CA2518408A1 Controlled release polymeric gels |
| 09/23/2004 | CA2518406A1 Thiol-mediated drug attachment to targeting peptides |
| 09/23/2004 | CA2518216A1 Oral insulin therapies and protocol |
| 09/23/2004 | CA2517439A1 Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 09/23/2004 | CA2516338A1 Novel compositions containing fentanyl |
| 09/22/2004 | EP1460120A1 Anion generating material and skin treating agent using the same |
| 09/22/2004 | EP1460080A1 Direct compressible trehalose solids |
| 09/22/2004 | EP1459740A1 Compositions containing sucralose |
| 09/22/2004 | EP1459739A1 Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids |
| 09/22/2004 | EP1459738A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 09/22/2004 | EP1458870A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458646A1 Low water uptake silicas |
| 09/22/2004 | EP1458427A2 Compositions comprising collagen and metalloprotease inhibitors |